June is Alzheimer’s and Brain Awareness Month! According to the Alzheimer’s Association, Alzheimer’s disease is the 6th leading cause of death in the United States, with more than 5 million Americans currently living with it and someone new developing the disease every 66 seconds. This number could rise as high as 16 million by 2050 if no other advancements in researching the disease are made.
Clinical trials dedicated to ending Alzheimer’s disease are important for a number of reasons. Diseases that are more popularly researched, such as heart disease, have seen a decrease in deaths since 2000 while deaths from Alzheimer’s disease have increased by 89%. Sign up here for an Alzheimer’s disease clinical trial.
Alzheimer’s disease also impacts the caregivers that provide care and support for those suffering with the disease. 35% of caregivers for people with Alzheimer’s or another dementia report that their health has declined due to care responsibilities, compared to 19% of caregivers for older people without dementia. If you’re a caregiver looking for some simple tips on taking care of yourself, check out the 2017 Alzheimer’s Association Disease Facts and Figures.
ACMR hopes to help people achieve better physical and mental health through the work of clinical trials. Share this blog post with someone you know that’s interested in ending Alzheimer’s disease and furthering what we know about mental diseases and conditions.